Skip to main content

Introduction

Introduction
Welcome to Our Latest Installment of the Payers’ Guide to FDA Updates
Read More
Introduction
Welcome to the 2023 PAYERS’ GUIDE TO FDA UPDATES: Latest Approvals, Upcoming Decisions
Read More
Conference Highlights ASCO, Introduction
Precision Medicine and Immunotherapy Highlighted at ASCO 2018
Wayne Kuznar
Read More
FDA Approvals, Introduction, Payers' Guide
FDA Approvals in 2017 Represent a 21-Year High
Gary M. Owens, MD
Read More
Introduction
The Continuing Clinical and Economic Burden of Cardiometabolic Health
Dalia Buffery, MA, ABD
Read More
Introduction
Health Economics in Oncology: A Necessary Tool for Value-Based Patient Care
Dalia Buffery, MA, ABD
Read More
Introduction, Payers' Guide
New FDA Drug Approvals Hit an 18-Year High in 2014
Gary M. Owens, MD
Read More
Introduction
Cardiometabolic Health in 2014: Clinical and Economic Implications
Dalia Buffery, MA, ABD
Read More
Introduction
Cancer Care in 2014: Continuing Challenges, New Opportunities
Dalia Buffery, MA, ABD
Read More
Introduction
Cardiometabolic Risk Factors: Novel Approaches Can Improve Patient Outcomes
Dalia Buffery, MA, ABD
Read More
Page 1 of 2
Results 1 - 10 of 13